Diagnosis and management of dementia with Lewy bodiesIan G. McKeith, Ronald B. Postuma, Bradley F. Boeve et al.|Neurology|2017Cited by 4.4k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyMaarten J. Titulaer, Josep Dalmau, Lindsey McCracken et al.|The Lancet Neurology|2013Cited by 3.1k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's DiseaseStephen Salloway, H. Robert Brashear, Reisa A. Sperling et al.|New England Journal of Medicine|2014Cited by 2k
Research criteria for the diagnosis of prodromal dementia with Lewy bodiesIan G. McKeith, Tanis J. Ferman, Alan Thomas et al.|Neurology|2020Cited by 772
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseStephen Salloway, Michael Grundman, Reisa A. Sperling et al.|Neurology|2009Cited by 739